Eyepoint Pharmaceuticals Inc (EYPT) Insider Trading
- $120,833,415.84
- $50,777,804.13
- March 16, 2026
- Paul Ashton
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 1, 2012 | Director | 10,000 | $1.68 | Buy | $16,800.00 |
Insiders are both buying and selling Eyepoint Pharmaceuticals Inc stock.
The insider traders at Eyepoint Pharmaceuticals Inc are: Paul Ashton, Ew Healthcare Partners, L.P., Cormorant Asset Management, Lp, George Elston, Dario A Paggiarino, Ye Liu, David Scott Jones, Nancy Lurker, Jay S Duker, Leonard S. Ross, Lori Freedman, David R Guyer, John B Landis, Douglas Evan Godshall, Paul Hopper, Wendy F Dicicco, and Michael Craig Pine
The most active insider trader at Eyepoint Pharmaceuticals Inc is Paul Ashton with 8 trades.
Ye Liu has sold the most Eyepoint Pharmaceuticals Inc stock with a total value of $79,219,971.22.
Cormorant Asset Management, Lp has bought the most Eyepoint Pharmaceuticals Inc stock with a total value of $99,576,141.69.
The most recent insider trade for Eyepoint Pharmaceuticals Inc was on March 16, 2026.
The single biggest insider buy for Eyepoint Pharmaceuticals Inc was from Cormorant Asset Management, Lp with a total value of $41,873,823.74 on Dec. 4, 2023.
The single biggest insider sell for Eyepoint Pharmaceuticals Inc was from Ye Liu with a total value of $37,159,225.00 on Jan. 11, 2024.